A Decade of Research on the Quality of Systemic Cancer Therapy in Routine Care: What Aspects of Quality Are We Measuring?-Reference-Cited by-同舟云学术

A Decade of Research on the Quality of Systemic Cancer Therapy in Routine Care: What Aspects of Quality Are We Measuring?

Published:2015-01 Issue:1 Volume:11 Page:55-61
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Shen Shixin¹,Krzyzanowska Monika K.¹

Affiliation:

1. University of Toronto; Institute for Clinical Evaluative Sciences; and Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Abstract

Most studies evaluating quality of systemic cancer therapy have focused on access to cytotoxic chemotherapy in early-stage disease. Studies on other aspects of quality and in different clinical settings are needed.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2014.001564

Reference43 articles.

1. Defining indicators for measuring the quality of systemic cancer therapy using administrative data.

2. Impact of Patient and Provider Characteristics on the Treatment and Outcomes of Colorectal Cancer

3. Quality of Breast Cancer Care: What Do We Know?

4. The quality of chemotherapy and its quality assurance

5. What is grey literature? Grey Literature Report Web site New York Academy of Medicine www.greylit.org/about

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilities;European Journal of Cancer;2023-12

2. Measuring variation in the quality of systemic anti-cancer therapy delivery across hospitals: A national population-based evaluation;European Journal of Cancer;2023-01

3. The development of outcome key performance indicators for systemic anti‐cancer therapy using a modified Delphi method;European Journal of Cancer Care;2020-06-08

4. How to Undertake Outcomes Research in Oncology;Methods and Biostatistics in Oncology;2018

5. Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in Queensland;Asia-Pacific Journal of Clinical Oncology;2016-07-20